Clinical Trial

Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy

Name: Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy — clinical trial record (NCT05694598)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Multicenter, Open-Label, Non-Randomized, Uncontrolled Study of VGR-R01 in Patients with Bietti Crystalline Dystrophy.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2023-01-20.

Status change: Not Yet Recruiting → Active, Not Recruiting 2025-12-17

Trial Details

NCT Number	NCT05694598
Lead Sponsor	Shanghai Vitalgen BioPharma Co., Ltd.
Conditions	Bietti Crystalline Dystrophy
Enrollment	12 participants
Start Date	2023-03-27
Primary Completion	2024-09-13 (estimated)
Study Completion	2028-09-13 (estimated)
Updated on ClinicalTrials.gov	2025-12-24